Skip to main navigation Skip to search Skip to main content

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Humalog with an Open-Label Postprandial LY900014 Treatment Group in Children and Adolescents with Type 1 Diabetes PRONTO-Peds

Project: Research

Project Details

StatusFinished
Effective start/end date05/20/19 → 05/20/24

Funding

  • Lilly USA LLC: $42,561.00